MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
题目
MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study
作者
S. Harrison, S. Moussa, M. Bashir, N. Alkhouri, J. Frias, S. Baum, B. Tetri, M. Bansal, R. Taub
Scihuhuan